STAMIGEN Trademark

Trademark Overview


On Monday, April 10, 2023, a trademark application was filed for STAMIGEN with the United States Patent and Trademark Office. The USPTO has given the STAMIGEN trademark a serial number of 97881065. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, October 15, 2024. This trademark is owned by Liptis Pharmaceuticals USA Inc.. The STAMIGEN trademark is filed in the Pharmaceutical Products category with the following description:

Nutritional supplement
stamigen

General Information


Serial Number97881065
Word MarkSTAMIGEN
Filing DateMonday, April 10, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements


Goods and ServicesNutritional supplement

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 4, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLiptis Pharmaceuticals USA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSpring Valley, NY 10977

Party NameLiptis Pharmaceuticals USA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSpring Valley, NY 10977

Trademark Events


Event DateEvent Description
Thursday, April 13, 2023NEW APPLICATION ENTERED
Thursday, May 4, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 5, 2024ASSIGNED TO EXAMINER
Tuesday, January 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 16, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 17, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 17, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, January 17, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 17, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, January 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 15, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 15, 2024SOU EXTENSION 1 FILED
Tuesday, October 15, 2024SOU EXTENSION 1 GRANTED
Monday, October 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords


stamigen supplement nutritional